W
TEVA icon

WealthCollab’s Teva Pharmaceuticals TEVA Stock Holding History

WealthCollab’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6K Hold
756
– – 0.01% 357
2026
Q1 		$22.8K Hold
756
– – 0.01% 348
2025
Q4 		$23.6K Hold
756
– – 0.01% 354
2025
Q3 		$15.3K Hold
756
– – 0.01% 423
2025
Q2 		$12.7K Sell
756
-68
-8% -$1.1K 0.01% 438
2025
Q1 		$12.7K Buy
824
+68
+9% +$1.22K 0.01% 413
2024
Q4 		$16.7K Hold
756
– – 0.01% 349
2024
Q3 		$13.6K Hold
756
– – 0.01% 397
2024
Q2 		$12.3K Hold
756
– – 0.01% 399
2024
Q1 		$10.7K Hold
756
– – 0.01% 418
2023
Q4 		$7.89K Buy
+756
New +$7.06K 0.01% 465

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

WealthCollab's TEVA Position: Q2 2026 in Review

WealthCollab held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 756 shares worth $25.6K. The position accounts for 0.01% of the portfolio, ranked #357.

WealthCollab first reported a position in TEVA in Q4 2023 and has held it in 11 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • WealthCollab held 756 shares of Teva Pharmaceuticals worth $25.6K as of Q2 2026.
  • WealthCollab left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.01% of WealthCollab's portfolio in Q2 2026, its #357 holding.
  • WealthCollab first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.